Urinary Tubular Biomarkers for Chronic Kidney Disease
Recruiting · NCT06732349 · Observational (researchers observe without assigning treatment) · Lead sponsor: Erasmus Medical Center
View the official record on ClinicalTrials.gov →Interventions studied
Urinary tubular test panel
What this trial is about
Currently used tests for chronic kidney injury only assess the function of one part of the kidney: the filter called the glomerulus. The other part, called the tubule, is disregarded. Based on many previous studies, the investigators have good reason to assume that a better prediction of the course of chronic kidney disease by testing tubular function will be possible. This is important, for example, when patients need to be treated with kidney-protecting drugs.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Chronic kidney disease stage 3 (eGFR 30-59ml/min)
Exclusion criteria
- Active glomerulonephritis treated with immunosuppression
- Kidney transplant recipient
- Current treatment with chemo- or immunotherapy for malignancy
Where it is running
1 location listed.
- Erasmus MC - Rotterdam, South Holland, Netherlands